Table 1 Characteristics of secundiparas following a CD due to failed-VE, stratified by TOLAC versus planned CD

Factors at P1 (CD due to failed VE)

 gestation at delivery (mean ± std)

40.1 ± 1.4

39.7 ± 1.4

0.26

 indication for VE prolonged 2^nd stage N (%)

32 (56.1%)

9 (50%)

0.78

 persistent occiput posterior N (%)

8 (13.8%)

2 (11.1%)

1.0

 birthweight of new-born (mean ± std)

3395 g ± 363 g

3366 g ± 386 g

0.72

 macrosomia (> 4000 g) N (%)

4 (4.8%)

2 (7.7%)

0.62

 delivered elsewhere N (%)

32 (36.0%)

8 (30.8%)

0.81

Factors at P2 (TOLAC)

 maternal age (mean ± std)

27.4 ± 3.7

31.8 ± 5.7

 < 0.01

 artificial reproductive treatment N (%)

0

6 (30%)

 < 0.01

 interpregnancy interval, months (mean ± std)

29.2 ± 10.5

35.4 ± 17.7

0.07

 gestational hypertension N (%)

0

0

 gestational diabetes N (%)

3 (3.6%)

0

1.0

 gestation at delivery (mean ± std)

39.2 ± 1.8

37.6 ± 1.0

 < 0.01

 preterm delivery < 37 weeks N (%)

5 (5.6%)

1 (3.8%)

1.0

 thick meconium N (%)

5 (6.8%)

0 (0%)

NA

 new-born—male N (%)

44 (49.4%)

18 (69.2%)

0.12

 macrosomia (> 4000 g)

4 (4.5%)

0

0.57

 birthweight of new-born (mean ± std)

3300 g ± 466 g

3190 g ± 297 g

0.26

 delta birthweight of new-born (P2-P1) (mean ± std)

-73.1 g ± 450 g

-175 g ± 385 g

0.30

 delta birthweight of new-born > 500 g (P2 > P1) N (%)

12 (14.3%)

1 (3.8%)

0.29

 delta birthweight of new-born > 300 g (P2 > P1) N (%)

17 (20.2%)

2 (7.7%)

0.23

 delta birthweight of new-born > 500 g (P1 > P2) N (%)

18 (21.4%)

4 (15.5%)

0.58

 delta birthweight of new-born > 300 g (P1 > P2) N (%)

28 (33.3%)

7 (27.9%)

0.63